How do bone-active drugs increase patient survival? [ 2015 - ]

Research Grant

Researchers: Prof Michael Rogers (Principal investigator) ,  A/Pr Tri Phan ,  Dr Andrew Jenner ,  Prof Eva Segelov ,  Prof Jacqueline Center

Brief description Bisphosphonates are a class of drugs used to prevent bone destruction in diseases such as osteoporosis. Evidence is emerging that these drugs also act on cells outside the skeleton to have additional beneficial effects, for example prolonging patient survival. This project will identify the cells affected and the mechanisms involved. With this knowledge, these drugs could be used more effectively and in different ways for the prevention or treatment of cancer and chronic human illnesses.

Funding Amount $593,502.00

Funding Scheme Project Grants

Notes Standard Project Grant